Predictors of oxidative stress in heart failure patients with Cheyne-Stokes respiration

Sleep and Breathing

Volumn 15, Issue 4, 2011, Pages 827-835

  Krieger, Ana C ^a   Green, Daniel ^b   Cruz, Muriel T ^c   Modersitzki, Frank ^d   Yitta, Gita ^e   Jelic, Sanja ^f   Tse, Doris S ^d   Sedlis, Steven P ^c,d  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

Cheyne stokes respiration; Heart failure; Hypoxemia; Oxidative stress; Periodic breathing; Sleep apnea

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; HYDRALAZINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; REACTIVE OXYGEN METABOLITE; SPIRONOLACTONE;

ARTICLE; CHEYNE STOKES BREATHING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; FLUORESCENCE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HUMAN CELL; MALE; MORTALITY; NEUTROPHIL; OXIDATIVE STRESS; OXYGEN TENSION; POLYSOMNOGRAPHY; PREDICTION; PRIORITY JOURNAL; SLEEP; AGED; FEMALE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS; REFERENCE VALUE; RISK FACTOR;

AGED; CHEYNE-STOKES RESPIRATION; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; POLYSOMNOGRAPHY; PROGNOSIS; REACTIVE OXYGEN SPECIES; REFERENCE VALUES; RISK FACTORS;

EID: 84859376067     PISSN: 15209512     EISSN: 15221709     Source Type: Journal    
DOI: 10.1007/s11325-010-0444-2     Document Type: Article

References (49)

1. Mortara A, Sleight P, Pinna GD, Maestri R, Capomolla S, Febo O, La Rovere MT, Cobelli F (1999) Association between hemodynamic impairment and Cheyne-Stokes respiration and periodic breathing in chronic stable congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 84(8):900-904. doi:S0002-9149(99)00462-2
2. Fanfulla F, Mortara A, Maestri R, Pinna G, Bruschi C, Cobelli F, Rampulla C (1998) The development of hyperventilation in patients with chronic heart failure and Cheyne-Stokes respiration. Chest 114(4):1083-1090. doi:10.1378/chest.114.4.1083 (Pubitemid 28495906)
3. Javaheri S, Parker TJ, Liming JD, Corbett WS, Nishiyama H, Wexler L, Roselle GA (1998) Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation 97(21):2154-2159
4. Lofaso F, Verschueren P, Rande J, Harf A, Goldenberg F (1994) Prevalence of sleep-disordered breathing in patients on a heart transplant waiting list. Chest 106(6):1689-1694. doi:10.1378/chest.106.6.1689 (Pubitemid 24375127)
5. Bradley TD, Floras JS (2003) Sleep apnea and heart failure. Part II: central sleep apnea. Circulation 107(13):1822-1826. doi:10.1161/01.cir. 0000061758.05044.64
6. Hanly P, Zuberi-Khokhar N (1996) Increased mortality associated with Cheyne-Stokes respiration in patients with congestive heart failure. Am J Respir Crit Care Med 153(1):272-276 (Pubitemid 26026861)
7. Francis DP, Willson K, Davies LC, Coats AJS, Piepoli M (2000) Quantitative general theory for periodic breathing in chronic heart failure and its clinical implications. Circulation 102(18):2214-2221
8. Lanfranchi PA, Braghiroli A, Bosimini E, Mazzuero G, Colombo R, Donner CF, Giannuzzi P (1999) Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure. Circulation 99 (11):1435-1440 (Pubitemid 29140908)
9. Fanfulla F, Mortara A, Maestri R, Pinna GD, Bruschi C, Cobelli F, Rampulla CU (1998) The development of hyperventilation in patients with chronic heart failure and Cheyne-Stokes respiration: a possible role of chronic hypoxia. Chest 114(4):1083-1090 (Pubitemid 28495906)
10. Corra U, Pistono M, Mezzani A, Braghiroli A, Giordano A, Lanfranchi P, Bosimini E, Gnemmi M, Giannuzzi P (2006) Sleep and exertional periodic breathing in chronic heart failure: prognostic importance and interdependence. Circulation 113 (1):44-50. doi:10.1161/circulationaha.105.543173 (Pubitemid 43958487)
11. Bradley TD (2003) The ups and downs of periodic breathing: Implications for mortality in heart failure. J Am Coll Cardiol 41 (12):2182-2184. doi:10.1016/s0735-1097(03)00470-4
12. Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM, Francis GS, Ganiats TG, Goldstein S, Gregoratos G, Jessup ML, Noble RJ, Packer M, Silver MA, Stevenson LW, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Jacobs AK, Hiratzka LF, Russell RO, Smith SC (2002) Acc/aha guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. J Heart Lung Transplant 21(2):189-203. doi: S1053249801007768
13. Remme WJ, Swedberg K (2002) Comprehensive guidelines for the diagnosis and treatment of chronic heart failure. Task force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology. Eur J Heart Fail 4(1):11-22. doi:S1388984201002318
14. Guyatt G, Sullivan MJ, Thompson PJ, Fallen EL, Pugsley SO, Taylor DW, Berman LB (1985) The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J 8(132):919-923
15. Lipkin DP, Scriven A, Crake T, Poole-Wilson PA (1986) Six minute walking test for assessing exercise capacity in chronic heart failure. Br Med J (Clin Res Ed) 292(6521):653-655 (Pubitemid 16167425)
16. Krieger AC, Ayappa I, Norman RG, Rapoport DM (2000) Central vs. Obstructive respiratory events classified by nasal cannula/pressure transducer. Am J Respir Crit Care Med 161:A28, Abstract
17. Himmelfarb J, Hakim RM, Holbrook DG, Leeber DA, Ault KA (1992) Detection of granulocyte reactive oxygen species formation in whole blood using flow cytometry. Cytometry 13(1):83-89
18. Bass D, Parce J, Dechatelet L, Szejda P, Seeds M, Thomas M (1983) Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. J Immunol 130(4):1910-1917 (Pubitemid 13091657)
19. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW (2009) 2009 Focused update incorporated into the acc/aha 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on PracticeGuidelines developed in collaboration with the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 53(15):e1-e90. doi:10.1016/j.jacc.2008.11.013
20. Hanly PJ, Zuberi-Khokhar NS (1996) Increased mortality associated with Cheyne-Stokes respiration in patients with congestive heart failure. Am J Respir Crit Care Med 153 (1):272-276 (Pubitemid 26026861)
21. Javaheri S, Shukla R, Zeigler H, Wexler L (2007) Central sleep apnea, right ventricular dysfunction, and low diastolic blood pressure are predictors of mortality in systolic heart failure. J Am Coll Cardiol 49(20):2028-2034. doi:10.1016/j.jacc.2007.01.084 (Pubitemid 46734642)
22. Eleuteri EMF, Gnemmi I, Carbone M, Colombo M, La Rocca G, Anzalone R, Tarro Genta F, Zummo G, Di Stefano A, Giannuzzi P (2009) Role of oxidative and nitrosative stress biomarkers in chronic heart failure. Front Biosci 14:2230-2237
23. Michowitz Y, Kisil S, Guzner-Gur H, Rubinstein A, Wexler D, Sheps D, Keren G, George J (2008) Usefulness of serum myeloperoxidase in prediction of mortality in patients with severe heart failure. IMAJ 12:884-888
24. Keith M, Geranmayegan A, Sole MJ, Kurian R, Robinson A, Omran AS, Jeejeebhoy KN (1998) Increased oxidative stress in patients with congestive heart failure. J Am Coll Cardiol 31 (6):1352-1356. doi:S0735-1097(98)00101-6
25. Mak S, Newton GE (2001) The oxidative stress hypothesis of congestive heart failure: radical thoughts. Chest 120(6):2035-2046 (Pubitemid 34053470)
26. Poletti R, Passino C, Giannoni A, Zyw L, Prontera C, Bramanti F, Clerico A, Piepoli M, Emdin M (2009) Risk factors and prognostic value of daytime Cheyne-Stokes respiration in chronic heart failure patients. Int J Cardiol 137(1):47-53
27. Tan S, Zhou F, Nielsen VG, Wang Z, Gladson CL, Parks DA (1999) Increased injury following intermittent fetal hypoxia-reoxygenation is associated with increased free radical production in fetal rabbit brain. J Neuropathol Exp Neurol 58(9):972-981 (Pubitemid 29441925)
28. La Rocca G, Di Stefano A, Eleuteri E, Anzalone R, Magno F, Corrao S, Loria T, Martorana A, Di Gangi C, Colombo M, Sansone F, Patanè F, Farina F, Rinaldi M, Cappello F, Giannuzzi P, Zummo G (2009) Oxidative stress induces myeloperoxidase expression in endocardial endothelial cells from patients with chronic heart failure. Basic Res Cardiol 104 (3):307-320
29. Takenaka H, Kihara Y, Iwanaga Y, Onozawa Y, Toyokuni S, Kita T (2006) Angiotensin ii, oxidative stress, and extracellular matrix degradation during transition to lv failure in rats with hypertension. J Mol Cell Cardiol 41(6):989-997 (Pubitemid 44791331)
30. Zhang P, Hou M, Li Y, Xu X, Barsoum M, Chen Y, Bache RJ (2009) Nadph oxidase contributes to coronary endothelial dysfunction in the failing heart. Am J Physiol Heart Circ Physiol 296(3):H840-H846. doi:10.1152/ajpheart.00519.2008
31. Prabhakar NR (2001) Oxygen sensing during intermittent hypoxia: cellular andmolecular mechanisms. J Appl Physiol 90(5):1986-1994
32. Gottlieb JD, Schwartz AR, Marshall J, Ouyang P, Kern L, Shetty V, Trois M, Punjabi NM, Brown C, Najjar SS, Gottlieb SS (2009) Hypoxia, not the frequency of sleep apnea, induces acute hemodynamic stress in patients with chronic heart failure. J Am Coll Cardiol 54(18):1706-1712. doi:10.1016/j.jacc.2009.08.016
33. Fletcher EC, Lesske J, Qian W, Miller CC, Unger T (1992) Repetitive, episodic hypoxia causes diurnal elevation of blood pressure in rats. Hypertension 19(6 Pt 1):555-561
34. Bao G, Metreveli N, Li R, Taylor A, Fletcher EC (1997) Blood pressure response to chronic episodic hypoxia: role of the sympathetic nervous system. J Appl Physiol 83(1):95-101 (Pubitemid 27304736)
35. Floras JS (2009) Sympathetic nervous system activation in human heart failure: clinical implications of an updated model. J Am Coll Cardiol 54(5):375-385. doi:10.1016/j.jacc.2009.03.061
36. Dyugovskaya L, Lavie P, Lavie L (2002) Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 165(7):934-939 (Pubitemid 34774660)
37. Bitter T, Westerheide N, Faber L, Hering D, Prinz C, Langer C, Horstkotte D, Oldenburg O (2010) Adaptive servoventilation in diastolic heart failure and Cheyne-Stokes respiration. Eur Respir J 36:385-392. doi:10.1183/09031936. 00045609
38. Oldenburg O, Bitter T, Schmidt A, Wellmann B, Lehmann R, Prinz C, Langer C, Horstkotte D (2008) Treatment of nocturnal cheyne - stokes - respiration by adaptive servoventilation improves sleep disordered breathing and cardiopulmonary function in patients with chronic heart failure. Circulation 118 (18):S717A (abstract)
39. Olson LJ, Somers VK (2007) Treating central sleep apnea in heart failure: outcomes revisited. Circulation 115(25):3140-3142. doi:10.1161/circulationaha. 107.709303 (Pubitemid 47012227)
40. Scharf C, Turk A, Brack T, Bloch K (2005) Cardiac resynchronization therapy, central sleep apnea, and Cheyne-Stokes respiration in chronic heart failure patients. J Am Coll Cardiol 45(4):633. doi:10.1016/j.jacc.2004.11.028
41. Sinha A-M, Skobel EC, Breithardt O-A, Norra C, Markus KU, Breuer C, Hanrath P, Stellbrink C (2004) Cardiac resynchronization therapy improves central sleep apnea and Cheyne-Stokes respiration in patients with chronic heart failure. J Am Coll Cardiol 44(1):68-71. doi:10.1016/j.jacc.2004.03.040 (Pubitemid 38968459)
42. Stellbrink C, Skobel E, Sinha A-M (2005) Cardiac resynchronization therapy, central sleep apnea, and Cheyne-Stokes respiration in chronic heart failure patients: reply. J Am Coll Cardiol 45 (4):633-634. doi:10.1016/j.jacc. 2004.11.027 (Pubitemid 40222263)
43. Andreas S, Weidel K, Hagenah G, Heindl S (1998) Treatment of Cheyne-Stokes respiration with nasal oxygen and carbon dioxide. Eur Respir J 12(2):414-419 (Pubitemid 28389538)
44. Franklin KA, Eriksson P, Sahlin C, Lundgren R (1997) Reversal of central sleep apnea with oxygen. Chest 111(1):163-169 (Pubitemid 27043624)
45. Krachman SL, D'Alonzo GE, Berger TJ, Eisen HJ (1999) Comparison of oxygen therapy with nasal continuous positive airway pressure on Cheyne-Stokes respiration during sleep in congestive heart failure. Chest 116(6):1550-1557 (Pubitemid 30012693)
46. Soll BA, Yeo KK, Davis JW, Seto TB, Schatz IJ, Shen EN (2009) The effect of posture on Cheyne-Stokes respirations and hemodynamics in patients with heart failure. Sleep 32(11):499-506
47. Lorenzi-Filho G, Rankin F, Bies I, Bradley TD (1999) Effects of inhaled carbon dioxide and oxygen on Cheyne-Stokes respiration in patients with heart failure. Am J Respir Crit Care Med 159 (5):1490-1498 (Pubitemid 29227859)
48. Andreas S, Clemens C, Sandholzer H, Figulla H, Kreuzer H (1996) Improvement of exercise capacity with treatment of Cheyne-Stokes respiration in patients with congestive heart failure. J Am Coll Cardiol 27(6):1486-1490 (Pubitemid 26153284)
49. Naughton MT, Benard DC, Liu PP, Rutherford R, Rankin F, Bradley TD (1995) Effects of nasal cpap on sympathetic activity in patients with heart failure and central sleep apnea. Am J Respir Crit Care Med 152(2):473-479